Sharks, beauty and synthetic biotech
Synthetic biotechnology is projected to surpass $61 billion in revenue by 2030, driven by companies interested in shifting sourcing strategies away from petrochemicals or practices harmful for biodiversity.
Blog
Post a comment
You must be logged in to post a comment.